Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16093464 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PaTH Study: Parathyroid Hormone and Alendronate for Osteoporosis
Condition: Osteoporosis
Interventions: Drug: PTH;   Drug: Alendronate

Indicates status has not been verified in more than two years